CD53 and diabetes mellitus: While not a cell surface antigen, a lack of TSPO expression, a drug target for diabetes and obesity [31], was observed to uniquely characterize undifferentiated NP88 and NP110 progenitors (Additional file 8: Figure S4 and Additional file 7: Table S4).